Log in
Enquire now
Azafaros

Azafaros

Developer of therapeutics for rare lysosomal storage disorders.

OverviewStructured DataIssuesContributors

Contents

azafaros.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Pharmaceutical industry
Pharmaceutical industry
Biotechnology
Biotechnology
Manufacturing
Manufacturing
Health technology
Health technology
Location
Switzerland
Switzerland
Netherlands
Netherlands
CEO
‌
Stefano Portolano
Number of Employees (Ranges)
11 – 50
Email Address
info@azafaros.com
Investors
BioMedPartners
BioMedPartners
0
Jeito Capital
Jeito Capital
The Pictet Group
The Pictet Group
Forbion Capital Partners
Forbion Capital Partners
Seroba Life Science
Seroba Life Science
BioGeneration Ventures
BioGeneration Ventures
‌
Schroders Capital
Founded Date
2018
Total Funding Amount (USD)
174,500,000
Latest Funding Round Date
May 13, 2025
Latest Funding Type
Series B
Series B
COO
‌
Silvia Ragno
Country
Netherlands
Netherlands
Headquarters
Naarden
Naarden

Other attributes

Latest Funding Round Amount (USD)
147,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Azafaros

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.